These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 35420934)
1. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Gosis BS; Wada S; Thorsheim C; Li K; Jung S; Rhoades JH; Yang Y; Brandimarto J; Li L; Uehara K; Jang C; Lanza M; Sanford NB; Bornstein MR; Jeong S; Titchenell PM; Biddinger SB; Arany Z Science; 2022 Apr; 376(6590):eabf8271. PubMed ID: 35420934 [TBL] [Abstract][Full Text] [Related]
2. Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease Liu H; Chen Y; Wen Y; Zhu S; Huang S; He L; Hou S; Lai X; Chen S; Dai Z; Liang J J Agric Food Chem; 2021 Aug; 69(31):8671-8683. PubMed ID: 34342231 [TBL] [Abstract][Full Text] [Related]
3. Folliculin promotes substrate-selective mTORC1 activity by activating RagC to recruit TFE3. Li K; Wada S; Gosis BS; Thorsheim C; Loose P; Arany Z PLoS Biol; 2022 Mar; 20(3):e3001594. PubMed ID: 35358174 [TBL] [Abstract][Full Text] [Related]
4. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease. Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836 [TBL] [Abstract][Full Text] [Related]
5. SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling. Shimano H J Mol Med (Berl); 2007 May; 85(5):437-44. PubMed ID: 17279346 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. Zhang M; Chi X; Qu N; Wang C Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473 [TBL] [Abstract][Full Text] [Related]
7. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype. Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831 [TBL] [Abstract][Full Text] [Related]
8. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis. Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008 [TBL] [Abstract][Full Text] [Related]
9. FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation. Fujinuma S; Nakatsumi H; Shimizu H; Sugiyama S; Harada A; Goya T; Tanaka M; Kohjima M; Takahashi M; Izumi Y; Yagi M; Kang D; Kaneko M; Shigeta M; Bamba T; Ohkawa Y; Nakayama KI Cell Rep; 2023 May; 42(5):112530. PubMed ID: 37209098 [TBL] [Abstract][Full Text] [Related]
10. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. Liu X; Chen S; Zhang L Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319 [TBL] [Abstract][Full Text] [Related]
11. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis. Uehara K; Sostre-Colón J; Gavin M; Santoleri D; Leonard KA; Jacobs RL; Titchenell PM Cell Mol Gastroenterol Hepatol; 2022; 13(6):1625-1647. PubMed ID: 35240344 [TBL] [Abstract][Full Text] [Related]
12. Connecting mTORC1 signaling to SREBP-1 activation. Bakan I; Laplante M Curr Opin Lipidol; 2012 Jun; 23(3):226-234. PubMed ID: 22449814 [TBL] [Abstract][Full Text] [Related]
13. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Ren T; Zhu J; Zhu L; Cheng M Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426 [TBL] [Abstract][Full Text] [Related]
14. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis. Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523 [TBL] [Abstract][Full Text] [Related]
15. The ménage à trois of autophagy, lipid droplets and liver disease. Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741 [TBL] [Abstract][Full Text] [Related]
16. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. Liu K; Qiu D; Liang X; Huang Y; Wang Y; Jia X; Li K; Zhao J; Du C; Qiu X; Cui J; Xiao Z; Qin Y; Zhang Q Autophagy; 2022 Apr; 18(4):860-876. PubMed ID: 34382907 [TBL] [Abstract][Full Text] [Related]
17. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway. Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744 [TBL] [Abstract][Full Text] [Related]